COSMO BIO COMPANY,LIMITED [3386.T]
TOKYO, Apr 21 (Pulse News Wire) – Cosmo BIO Company,limited (3386.T) completed the issuance of restricted shares to its directors. The issuance was approved during the board meeting held on March 24, 2026.
A total of 3,000 ordinary shares were distributed at a price of ¥1,258 per share, amounting to a total value of ¥3.8 million. The shares were allocated to three directors and one subsidiary director, excluding audit committee members and outside directors. The distribution includes a restriction on transferring the shares until the interim report for the fiscal year containing the delivery date is submitted.
Additionally, since the total issuance value is less than ¥100 million, there is no requirement to file securities notification documents or temporary reports under the Financial Instruments and Exchange Act. For employees, the payment schedule is set for May 21, 2026. In related news, the restricted stock compensation program was introduced in the fiscal year 2021 to incentivize sustainable growth within the group and enhance shareholder value alignment.
Under this scheme, the company provides monetary reward claims to eligible directors, who then contribute these funds towards acquiring ordinary shares of the company.
🟢 Confidence: High AI-translated content.